John P. Schmid, Director at Design Therapeutics, Inc. (DSGN), bought 44,774 shares at $3.74 ($166K) on 2024-03-25, disclosed to the SEC on 2024-03-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.62 | 9,156 | $33K | 19.9% |
| 2 | $3.74 | 17,809 | $67K | 40.0% |
| 3 | $3.74 | 17,809 | $67K | 40.0% |
| Total | $3.72 avg | 44,774 | $166K | 100% |
| Filing → |
| XERS | BUY | 2024-08-13 | $10K | — | Filing → |
| XERS | BUY | 2024-08-12 | $10K | — | Filing → |
| XERS | BUY | 2024-05-10 | $10K | — | Filing → |